Predict your next investment

HEALTHCARE | Stealth Mode

See what CB Insights has to offer

Stage

Unattributed - III | Alive

Total Raised

$5.95M

Last Raised

$1.33M | 3 yrs ago

About NanoPharmaceuticals

NanoPharmaceuticals is a stealth pharmaceutical company.

NanoPharmaceuticals Headquarter Location

1 Discovery Drive

Rensselaer, New York, 12144,

United States

917-612-1105

Latest NanoPharmaceuticals News

Global $68.4 Bn Nanobiotechnology Markets to 2026: Focus on Nanopharmaceuticals, Development of Nanopharmaceuticals, Biomolecular Engineering, Tissue Engineering, Nanostructures, Bioprocessing

Jul 27, 2021

Dublin, IRELAND Dublin, July 27, 2021 (GLOBE NEWSWIRE) -- The "Nanobiotechnology: Applications and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for nanobiotechnology should grow from $38.5 billion in 2021 to $68.4 billion by 2026, at a compound annual growth rate (CAGR) of 12.2% for the period of 2021-2026. The scope of this investigation includes the major viable nanobiotechnologies that are currently being implemented in various industries. The study scope includes the major nanotechnology formats that will or likely become commercialized within the next 5 years. Each technology format is analyzed to determine its market status, impact on future market segments and forecasted growth from 2021 through 2026. Given the emerging nature of this industry, it is time to analyze the key trends, markets and industry dynamics to provide a useful basis for decision-making. In many industries, including the biotechnology industry, nanotechnology is emerging as the platform for materials. The unique properties of nanomaterials allow for added value in a variety of applications, from drug encapsulation and release to biological imaging. At the same time, the pharmaceutical industry is seeking ways to expand patenting and improve pharmacokinetics. In addition, the diagnostics industry is looking for ways to improve the molecular image of new pharmaceutical products. These converging forces result in nanobiotechnology being used in a variety of applications and materials. Several nanotechnology platforms are already established and providing significant revenues in drug delivery applications, as well as diagnostics, microbicides and R&D tools. Significant nanotechnology drug formats include polymer, liposomal and nanocrystal drugs. Diagnostic and microbicide formats include nanoparticles, quantum dots and dendrimers. Nanopore formats are emerging in third generation DNA sequencing applications. The purpose of this report is to provide a global, regional and national assessment of the nanobiotechnology application market's potential as well as its existing products, services, future market sizes. This is important because nanobiotechnology markets vary substantially in terms of regional characteristics and depending on the technology in question. Technology issues and market-driving forces are discussed. Influencing factors, including drug delivery needs, biologic imaging trends and industry structure, are also discussed. The publisher examines nanobiotechnology companies and industry alliances, nanomaterial consumption, end-user industry, and market-driving forces. The Report Includes: Analyses of the global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026 Estimation of the market size and market forecast for nanobiotechnology applications, and corresponding market share analysis by molecular diagnostic application, therapeutic application, biopharmaceutical application, and geography Highlights of key market dynamics, issues and trends, gaps and opportunities influencing current and future demand for nanobiotechnology in the global market and its sub-segments Regional outlook and a country level assessment of nanobiotechnology applications market considering all macroeconomic factors, and Covid-19 impact analysis within the industry Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages Discussion of major market segments and their respective technologies in the overall global market for nanobiotechnology Assessment of major stakeholders and analysis of the key competitive landscape based on recent developments and segmental revenues Profile descriptions of the leading industry players including Ablynx, Arrowhead Pharmaceuticals Inc., Celgene Corp., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Bio-Gate AG, Nanophase Technologies Corp., and Starpharma Holdings Ltd. Key Topics Covered: Market Definition Scope of the Report Analyst's Credentials

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

NanoPharmaceuticals Patents

NanoPharmaceuticals has filed 19 patents.

The 3 most popular patent topics include:

  • Transcription factors
  • Clusters of differentiation
  • Integrins
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/30/2019

8/3/2021

Clusters of differentiation, Transcription factors, Ion channels, Integrins, Amines

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/30/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/3/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Clusters of differentiation, Transcription factors, Ion channels, Integrins, Amines

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.